Padmanee Sharma

The University of Texas MD Anderson Cancer Center

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 4%percentile

0.700Author DataRank

Indexed papers

3in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Author response: The Human Cell Atlas

(2017)10.7554/elife.27041.011

Top 29%

0.700DataRank

Top 29%14 citations

Sarah A. Teichmann, Matthew E. Hurles, Ido Amit, Kerstin Lindblad‐Toh, Bernd Bodenmiller +60 more

Papers

Driven by 39 papers — median percentile 71. Top paper: “Nivolumab Plus Ipilimumab for Metastatic Castration-Resistant Prostate Cancer: Preliminary Analysis of Patients in the CheckMate 650 Trial”.

Nivolumab Plus Ipilimumab for Metastatic Castration-Resistant Prostate Cancer: Preliminary Analysis of Patients in the CheckMate 650 Trial

Cancer Cell(2020)10.1016/j.ccell.2020.08.007

N/A

4.8DataRank · unranked

398 citations

Russell K. Pachynski, Vivek Narayan, Aude Fléchon, Gwénaëlle Gravis, Matthew D. Galsky +10 more

Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity

Cancer Cell(2022)10.1016/j.ccell.2022.04.004

N/A

4.7DataRank · unranked

350 citations

Daniel H. Johnson, Noha Abdel‐Wahab, Wai Chin Foo, Salah-Eddine Bentebibel, May Daher +32 more

Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trial

The Lancet. Gastroenterology & hepatology(2022)10.1016/s2468-1253(21)00427-1

N/A

4.7DataRank · unranked

263 citations

Elshad Hasanov, Hop Sanderson Tran Cao, Lianchun Xiao, Jean‐Nicolas Vauthey, Sunyoung S. Lee +24 more

Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial

Nature Medicine(2023)10.1038/s41591-022-02189-0

N/A

4.1DataRank · unranked

213 citations

Cheuk Hong Leung, Annikka Weissferdt, Apar Pataer, Brett W. Carter, Myrna C. B. Godoy +52 more

Nodal immune flare mimics nodal disease progression following neoadjuvant immune checkpoint inhibitors in non-small cell lung cancer

Nature Communications(2021)10.1038/s41467-021-25188-0

N/A

3.1DataRank · unranked

110 citations

Annikka Weissferdt, Myrna C. B. Godoy, William N. William, Cheuk Hong Leung, Heather Lin +23 more

Pre-existing immune status associated with response to combination of sipuleucel-T and ipilimumab in patients with metastatic castration-resistant prostate cancer

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2020-002254

N/A

1.6DataRank · unranked

72 citations

Li Zhang, Sumit K. Subudhi, Brandon Chen, Jaqueline Marquez, Eric V Liu +12 more

Combined CTLA-4 and PD-L1 blockade in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer is associated with increased myeloid and neutrophil immune subsets in the bone microenvironment

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-002919

N/A

1.6DataRank · unranked

56 citations

Bilal A. Siddiqui, Ana M. Aparicio, Shalini S. Yadav, Sreyashi Basu, Hong Chen +8 more

Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients

Science(2018)10.1126/science.aan4236

N/A

1.3DataRank · unranked

4585 citations

C. N. Spencer, Luigi Nezi, Alexandre Reuben, Miles C. Andrews, Tatiana V. Karpinets +89 more

B cells and tertiary lymphoid structures promote immunotherapy response

Nature(2020)10.1038/s41586-019-1922-8

N/A

1.2DataRank · unranked

2719 citations

Sangeetha M. Reddy, Jianjun Gao, Shaojun Zhang, Rafet Başar, Rohit Thakur +55 more

Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade

Cancer Discovery(2016)10.1158/2159-8290.cd-15-1545

N/A

1.0DataRank · unranked

1012 citations

Whijae Roh, Alexandre Reuben, Zachary A. Cooper, Christine N. Spencer, Peter A. Prieto +39 more

Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade

Nature Medicine(2021)10.1038/s41591-021-01406-6

N/A

0.910DataRank · unranked

429 citations

Connie P. M. Duong, Vancheswaran Gopalakrishnan, Valerio Iebba, W. S. Chen, Lisa Derosa +66 more

Neoadjuvant relatlimab and nivolumab in resectable melanoma

Nature(2022)10.1038/s41586-022-05368-8

N/A

0.874DataRank · unranked

339 citations

Michael A. Postow, Elizabeth M. Burton, Michael T. Tetzlaff, Merrick I. Ross, Carlos A. Torres‐Cabala +35 more

Exercise Training Reduces the Inflammatory Response and Promotes Intestinal Mucosa-Associated Immunity in Lynch Syndrome

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-0088

N/A

0.780DataRank · unranked

23 citations

Laura Reyes-Uribe, Johannes F. Fahrmann, Whittney S. Thoman, Mark F. Munsell, Jennifer B. Dennison +21 more

Single cell T cell landscape and T cell receptor repertoire profiling of AML in context of PD-1 blockade therapy

Nature Communications(2021)10.1038/s41467-021-26282-z

N/A

0.734DataRank · unranked

132 citations

Dapeng Hao, Katarzyna Tomczak, Praveen Barrodia, Jin S. Im, Patrick K. Reville +28 more

Author response: The Human Cell Atlas

(2017)10.7554/elife.27041.011

Top 29%

0.700DataRank

Top 29%14 citations

Sarah A. Teichmann, Matthew E. Hurles, Ido Amit, Kerstin Lindblad‐Toh, Bernd Bodenmiller +60 more

A phase 1-2 trial of sitravatinib and nivolumab in clear cell renal cell carcinoma following progression on antiangiogenic therapy

Science Translational Medicine(2022)10.1126/scitranslmed.abm6420

N/A

0.633DataRank · unranked

67 citations

Sangeeta Goswami, Peter F. Thall, Xuemei Wang, Ying Yuan, Eric Jonasch +21 more

Beta-Blocker Use Is Associated With Worse Relapse-Free Survival in Patients With Head and Neck Cancer

JCO Precision Oncology(2023)10.1200/po.22.00490

N/A

0.449DataRank · unranked

19 citations

Weilu Zhao, Shorook Na’ara, Frederico O. Gleber‐Netto, Tongxin Xie, Shahrukh R. Ali +12 more

Immune and pathologic responses in patients with localized prostate cancer who received daratumumab (anti-CD38) or edicotinib (CSF-1R inhibitor)

Journal for ImmunoTherapy of Cancer(2023)10.1136/jitc-2022-006262

N/A

0.449DataRank · unranked

19 citations

Brian F. Chapin, Sonali Jindal, Fei Duan, Sreyashi Basu, Shalini S. Yadav +16 more

Investigative needle core biopsies support multimodal deep-data generation in glioblastoma

Nature Communications(2025)10.1038/s41467-025-58452-8

N/A

0.442DataRank · unranked

18 citations

Sreyashi Basu, Gerard Baquer, Ryuhjin Ahn, Jennifer Gantchev, Sonali Jindal +71 more

Immune checkpoint inhibitors plus debulking surgery for patients with metastatic renal cell carcinoma: clinical outcomes and immunological correlates of a prospective pilot trial

Nature Communications(2025)10.1038/s41467-025-57009-z

N/A

0.406DataRank · unranked

14 citations

Jianjun Gao, Sreyashi Basu, Daniel D. Shapiro, José A. Karam, Rebecca S. Tidwell +22 more

The impact of prior radiation therapy on outcome in a phase 2 trial combining sipuleucel-T (SipT) and ipilimumab (Ipi) in patients (pts) with metastatic castration resistant prostate cancer (mCRPC).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.5045

N/A

0.241DataRank · unranked

4 citations

Meenal Sinha, Sumit K. Subudhi, Brandon Chen, Jaqueline Marquez, Eric Liu +12 more

Single-cell Characterization of Acute Myeloid Leukemia and its Microenvironment Following PD-1 Blockade Based Therapy

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.09.03.278309

N/A

0.208DataRank · unranked

3 citations

Dapeng Hao, Katarzyna Tomczak, Praveen Barrodia, Jin S. Im, Patrick K. Reville +22 more

Author Correction: Neoadjuvant relatlimab and nivolumab in resectable melanoma

Nature(2023)10.1038/s41586-023-05892-1

N/A

0.165DataRank · unranked

2 citations

Michael A. Postow, Elizabeth M. Burton, Michael T. Tetzlaff, Merrick I. Ross, Carlos A. Torres‐Cabala +35 more

EON: Phase II trial of etigilimab (MPH313) in combination with nivolumab in patients with recurrent platinum-resistant clear cell ovarian cancer.

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.16_suppl.5573

N/A

0.104DataRank · unranked

1 citations

Emily Hinchcliff, Shuqi Wang, Amir A. Jazaeri, Anil K. Sood, Bryan Fellman +14 more

Investigative needle core biopsies for multi-omics in Glioblastoma

medRxiv(2023)10.1101/2023.12.29.23300541

N/A

0DataRank · unranked

6 citations

Sreyashi Basu, Gerard Baquer, Ryuhjin Ahn, Jennifer Gantchev, Sonali Jindal +44 more

TSG-6+ cancer-associated fibroblasts modulate myeloid cell responses and impair anti-tumor response to immune checkpoint therapy in pancreatic cancer

Nature Communications(2024)10.1038/s41467-024-49189-x

N/A

0DataRank · unranked

19 citations

Shelley M. Herbrich, Sangeeta Goswami, Baoxiang Guan, Yulong Chen, Marc Macaluso +12 more

Molecular Pathways and Cellular Subsets Associated with Adverse Clinical Outcomes in Overlapping Immune-Related Myocarditis and Myositis

Cancer Immunology Research(2024)10.1158/2326-6066.cir-24-0011

N/A

0DataRank · unranked

15 citations

Nicolas L. Palaskas, Sreyashi Basu, Yibo Dai, Zhong He, Shalini S. Yadav +12 more

A Modular Trial of Androgen Signaling Inhibitor Combinations Testing a Risk-Adapted Strategy in Patients with Metastatic Castration–Resistant Prostate Cancer

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-23-3740

N/A

0DataRank · unranked

6 citations

Rebecca S. Tidwell, Shalini S. Yadav, Jiun‐Sheng Chen, Miao Zhang, Jingjing Liu +22 more

TET2-mutant clonal hematopoiesis enhances macrophage antigen presentation and improves immune checkpoint therapy in solid tumors

Cancer Cell(2025)10.1016/j.ccell.2025.09.011

N/A

0DataRank · unranked

13 citations

Mehdi Chaib, Swetha Anandhan, Samuel W. Andrewes, Ashwat Nagarajan, Baoxiang Guan +5 more

Neoadjuvant immune checkpoint therapy: Enabling insights into fundamental human immunology and clinical benefit

Cancer Cell(2025)10.1016/j.ccell.2025.03.005

N/A

0DataRank · unranked

12 citations

Omar Alhalabi, Sangeeta Goswami, Padmanee Sharma, Kristen E. Pauken

Multimodal spatial proteomic profiling in acute myeloid leukemia

npj Precision Oncology(2025)10.1038/s41698-025-00897-7

N/A

0DataRank · unranked

10 citations

Ivo Veletić, Christopher D. Pacheco, Enes Dasdemir, Fatima Zahra Jelloul, Sammy Ferri‐Borgogno +15 more

Infliximab for Grade III or IV Immune Checkpoint Inhibitor Nephritis Clinical and Translational Evidence

Kidney International Reports(2025)10.1016/j.ekir.2025.10.018

N/A

0DataRank · unranked

0 citations

Masroor Habeeb, Hong Chen, Zainab Alhamal, Omar Mamlouk, Heather Lin +7 more

Myeloid Cell–associated Resistance to PD-1/PD-L1 Blockade in Urothelial Cancer Revealed Through Bulk and Single-cell RNA Sequencing

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-4574

N/A

0DataRank · unranked

89 citations

John P. Sfakianos, Kristin G. Beaumont, Güray Aktürk, Amir Horowitz, Robert Sebra +16 more

Comprehensive Molecular Characterization Identifies Distinct Genomic and Immune Hallmarks of Renal Medullary Carcinoma

Cancer Cell(2020)10.1016/j.ccell.2020.04.002

N/A

0DataRank · unranked

143 citations

Gabriel G. Malouf, Xiaoping Su, Hui Yao, Durga Nand Tripathi, Melinda Soeung +35 more

A Genetic Mouse Model Recapitulates Immune Checkpoint Inhibitor–Associated Myocarditis and Supports a Mechanism-Based Therapeutic Intervention

Cancer Discovery(2020)10.1158/2159-8290.cd-20-0856

N/A

0DataRank · unranked

278 citations

Wouter C. Meijers, Margaret L. Axelrod, Nana-Ama A.S. Anang, Elles M. Screever, Elizabeth C. Wescott +22 more

Neuro-immune interactions and immuno-oncology

Trends in cancer(2023)10.1016/j.trecan.2023.05.002

N/A

0DataRank · unranked

77 citations

Shajedul Islam, Padmanee Sharma, Moran Amit, Narmina Khanmammadova

Myeloid cell-associated resistance to PD-1/PD-L1 blockade in urothelial cancer revealed through bulk and single-cell RNA sequencing

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.09.16.300111

N/A

0DataRank · unranked

20 citations

John P. Sfakianos, Kristin G. Beaumont, Güray Aktürk, Amir Horowitz, Robert Sebra +16 more

Hallmarks of response, resistance, and toxicity to immune checkpoint blockade

Cell(2021)10.1016/j.cell.2021.09.020

N/A

0DataRank · unranked

1654 citations

Beth A. Helmink, Padmanee Sharma, Jennifer A. Wargo, Golnaz Morad

Inflammation induced by tumor-associated nerves promotes resistance to anti-PD-1 therapy in cancer patients and is targetable by IL-6 blockade

Research Square(2023)10.21203/rs.3.rs-3161761/v1

N/A

0DataRank · unranked

10 citations

Erez N. Baruch, Priyadahrshini Nagarajan, Frederico O. Gleber‐Netto, Xiayu Rao, Tongxin Xie +34 more

Padmanee Sharma

Indexed papers

Top data-sharing exemplar

Papers